Standout Papers
Immediate Impact
6 from Science/Nature 140 standout
Citing Papers
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Standout
Works of A Austin being referenced
Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| A Austin | 551 | 127 | 189 | 338 | 205 | 21 | 821 | |
| Kent R. Wehmeier | 506 | 154 | 126 | 344 | 213 | 16 | 885 | |
| Damien Denimal | 448 | 159 | 132 | 381 | 181 | 41 | 801 | |
| Saeed Esmaili | 757 | 95 | 336 | 218 | 135 | 18 | 917 | |
| Eunice Xiang Xuan Tan | 666 | 138 | 340 | 282 | 111 | 25 | 874 | |
| Dan‐Qin Sun | 495 | 116 | 204 | 211 | 180 | 32 | 795 | |
| Sung‐Kil Lim | 400 | 86 | 72 | 315 | 196 | 20 | 851 | |
| E. Fatta | 728 | 113 | 265 | 365 | 98 | 15 | 889 | |
| Yasushi Ide | 441 | 117 | 165 | 268 | 102 | 19 | 689 | |
| Kerry–Lee Milner | 662 | 99 | 212 | 294 | 158 | 13 | 968 | |
| E. Vanni | 706 | 94 | 141 | 421 | 138 | 23 | 843 |
All Works
Login with ORCID to disown or claim papers
Loading papers...